期刊文献+

叶下珠复方Ⅱ号对肝癌Huh7细胞miR-122表达及IGF-1R信号通路的调控作用 被引量:6

Regulatory Effect of Compound Phyllanthus urinsria II on miR-122 Expression and IGF-1R Signaling Pathway in Hepatoma Huh7 Cells
下载PDF
导出
摘要 目的观察叶下珠复方Ⅱ号对肝癌Huh7细胞miR-122表达及胰岛素样生长因子-1受体(IGF-1R)信号通路的影响,探讨其抗肝癌作用机制。方法采用反义寡核苷酸技术(siRNA)建立miR-122表达抑制肝癌Huh7细胞株(anti-miR-122-Huh7细胞)。体外培养Huh7、anti-miR-122-Huh7细胞,分别设置对照组、叶下珠复方Ⅱ号高剂量组(3.0 mg·mL^-1)和低剂量组(1.5 mg·mL^-1)。采用噻唑蓝(MTT)比色法检测2种细胞增殖;流式细胞术检测anti-miR-122-Huh7细胞调亡;采用qRT-PCR法和Western Blot法分别检测miR-122及其转录因子C/EBPα、靶基因IGF-1R及下游AKT3、KRAS、ERK1和CyclinG1基因表达。结果与肝癌Huh7细胞比较,anti-miR-122-Huh7细胞miR-122的表达显著下降、靶基因IGF-1R蛋白表达明显升高(P<0.05),miR-122表达抑制肝癌Huh7细胞构建成功。与对照组比较,叶下珠复方Ⅱ号高、低剂量组作用于肝癌Huh7细胞后,可以显著上调miR-122的表达(P<0.05),并下调IGF-1R mRNA的表达(P<0.05);叶下珠复方Ⅱ号高、低剂量组均可显著抑制Huh7、anti-miR-122-Huh7细胞的增殖(P<0.05),且对anti-miR-122-Huh7细胞抑制作用更为明显(与Huh7细胞比较,P<0.05)。与对照组比较,叶下珠复方Ⅱ号高、低剂量组作用于anti-miR-122-Huh7细胞后,细胞晚期凋亡率及总凋亡率均显著升高(P<0.05);高剂量组的miR-122表达及miR-122的上游转录因子C/EBPα的mRNA和蛋白表达明显上调(P<0.05);高、低剂量组的IGF-1R及下游AKT3、KRAS、CyclinG1基因的mRNA、蛋白表达均显著下调(P<0.05),且ERK1蛋白表达亦明显下调(P<0.05)。结论叶下珠复方Ⅱ号可能通过提高miR-122的表达,抑制IGF-1R信号通路活化,从而抑制肝癌Huh7细胞增殖和促进其凋亡。 Objective To observe the effect of Compound Phyllanthus urinsria Ⅱ(CPU Ⅱ) on the expression of miR-122 and IGF-1 R signaling pathway in hepatoma Huh7 cells,and to explore its anti-hepatocarcinogenesis mechanism.Methods miR-122 expression inhibited liver cancer Huh7 cell line(anti-miR-122-Huh7 cells) was established using antisense oligonucleotide technology(siRNA).Huh7 cells and anti-miR-122-Huh7 cells were cultured in vitro,and the control group,high-dose CPU Ⅱ group(3.0 mg·mL^-1) and low-dose CPU Ⅱ group(1.5 mg·mL^-1) were set.The proliferation of cells were detected by Thiazolyl blue(MTT) colorimetry.Apoptosis of antimiR-122 Huh7 cells were detected by Annexin V-FITC/PI flow cytometry.The expression of miR-122 and its transcription factor C/EBPα,target gene IGF-1 R and downstream genes AKT3,KRAS,ERK1 and CyclinGl were detected by qRT-PCR and Western Blot.Results Compared with hepatoma Huh7 cells,anti-miR-122-Huh7 cells showed a significant decrease in miR-122 expression and a significant increase in target gene IGF-1 R protein expression,which indicates that the miR-122 expression inhibited liver cancer Huh7 cells were successfully established.Compared with the control group,the high-and low-dose CPU Ⅱ significantly up-regulated the expression of miR-122(P<0.05) and down-regulated the mRNA expression of IGF-1 R(P<0.05) in hepatoma Huh7 cells.The high-and low-dose CPU Ⅱ significantly inhibited the proliferation of Huh7 cells and anti-miR-122-Huh7 cells(P<0.05),and the inhibition effect of CPU Ⅱ on anti-miR-122-Huh7 cells was more obvious compared with that in Huh7 cells(P<0.05).Compared with the control group,after treating anti-miR-122-Huh7 cells with the high-and low-dose CPU Ⅱ,the late apoptotic rates and total apoptotic rates of the cells were significantly increased(P<0.05);the expression of miR-122 and the mRNA and protein expression of the upstream transcription factor C/EBPα of miR-122 in the high-dose CPU Ⅱ group were significantly up-regulated(P<0.05).The mRNA expression and protein expression of IGF-1 R and downstream genes AKT3,KRAS and CyclinGl in the high-and low-dose CPU Ⅱ group cells were significantly down-regulated(P<0.05),and the protein expression of ERK1 was significantly down-regulated(P<0.05).Conclusion CPU Ⅱ can inhibit the activation of IGF-1 R signaling pathway by increasing the expression of miR-122,thereby inhibit proliferation of Huh7 cells and promote their apoptosis.
作者 李俏敏 杜欣芸 李小翚 陈力文 李常青 LI Qiaomin;DU Xinyun;LI Xiaohui;CHEN Liwen;LI Changqing(Institute of Tropical Medicine,Guangzhou University of Chinese Medicine,Guangzhou 510405 Guangdong,China;School of Pharmaceutical Sciences,Guangzhou University of Chinese Medicine,Guangzhou 510006 Guangdong,China)
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2020年第1期21-28,共8页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 国家自然科学基金项目(81673861)
关键词 肝癌Huh7细胞 anti-miR-122-Huh7细胞 叶下珠复方Ⅱ号 增殖 凋亡 MIR-122 胰岛素样生长因子-1受体 Hepatoma Huh7 cells anti-miR-122-Huh7 cells Compound Phyllanthus urinsria Ⅱ proliferation apoptosis miR-122 IGF-1R
  • 相关文献

参考文献6

二级参考文献53

  • 1徐砺新,隋延仿,顾健人,李岱宗,王文亮,刘彦仿,张荣美.人肝细胞肝癌与正常肝组织内C/EBP的分布及其mRNA丰度分析[J].中华病理学杂志,1994,23(3):148-150. 被引量:1
  • 2Soresi Maurizio,Giannitrapani Lydia,D'Antona Fabio,Florena Ada Maria,La Spada Emanuele,Terranova Angela,Cervello Melchiorre,D'Alessandro Natale,Montalto Giuseppe.Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(16):2563-2568. 被引量:25
  • 3吕志敢,郭政.肿瘤坏死因子的研究进展[J].山西医科大学学报,2006,37(3):311-314. 被引量:78
  • 4Takiguchi M.The C/EBP family of transcription factors in the liver and other organs.Int J Exp Pathol.1998,79(6):369-91.
  • 5Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55(2):74-108.
  • 6Zhao H,Friedman RD,Fournier RE.The locus control region activates serpin gene expression through recruitment of liver specific transcription factors and RNA polymerase II.Mol Cell Biol,2007,27(15):5286-5295.
  • 7Tan EH,Hooi SC,Laban M,et al.CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.Cancer Res,2005,65(22):10330-10337.
  • 8Clotman F,Lannoy VJ,Reber M,et al.The onecut transcription factor HNF6 is required for normal development of the biliary tract.Development,2002,129(8):1819-1828.
  • 9Harris TE,Albrecht JH,Nakanishi M,et al.CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding.J Biol Chem,2001,276(31):29200-29209.
  • 10Nakazaki H. Preoperative and postoperative eyokines in patients with cancer [ J ]. Cancer, 1992,70( 3 ) : 709-713.

共引文献37

同被引文献48

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部